Ken Fisher's position in Crinetics Pharmaceuticals is currently worth $19.4 Million. That's 0.01% of their equity portfolio (325th largest holding). The first Crinetics Pharmaceuticals trade was made in Q3 2022. Since then Ken Fisher bought shares two more times and sold shares on two occasions. The stake costed the investor $12.7 Million, netting the investor a gain of 53% so far.